Abstract:SORT1 (sortilin 1), a member of the the Vps10 (vacuolar protein sorting 10) family, is involved in hepatic lipid metabolism by regulating very low-density lipoprotein (VLDL) secretion and facilitating the lysosomal degradation of CES1 (carboxylesterase 1), crucial for triglyceride (TG) breakdown in the liver. This study explores whether SORT1 is targeted for degradation by chaperone-mediated autophagy (CMA), a selective protein degradation pathway that directs proteins containing KFERQ-like motifs to lysosomes via LAMP2A (lysosomal-associated membrane protein 2A). Silencing LAMP2A or HSPA8/Hsc70 with siRNA increased cytosolic SORT1 protein levels. Leupeptin treatment induced lysosomal accumulation of SORT1, unaffected by si LAMP2A co-treatment, indicating CMA-dependent degradation. Human SORT1 contains five KFERQ-like motifs ( 658 VVTKQ 662 , 730 VREVK 734 , 733 VKDLK 737 , 734 KDLKK 738 , and 735 DLKKK 739 ), crucial for HSPA8 recognition; mutating any single amino acid within these motifs decreased HSPA8 binding. Furthermore, compromised CMA activity resulted in elevated SORT1-mediated degradation of CES1, contributing to increased lipid accumulation in hepatocytes. Consistent with in vitro findings, LAMP2A knockdown in mice exacerbated high-fructose diet-induced fatty liver, marked by increased SORT1 and decreased CES1 levels. Conversely, LAMP2A overexpression promoted SORT1 degradation and CES1D accumulation, counteracting fasting-induced CES1D suppression through CMA activation. Our findings reveal that SORT1 is a substrate of CMA, highlighting its crucial role in directing CES1 to lysosomes. Consequently, disrupting CMA-mediated SORT1 degradation significantly affects CES1-dependent TG hydrolysis, thereby affecting hepatic lipid homeostasis. Abbreviations : APOB: apolipoprotein B; CES1: carboxylesterase 1; CMA: chaperone-mediated autophagy; HSPA8/Hsc70: heat shock protein family A (Hsp70) member 8; LAMP2A: lysosomal associated membrane protein 2A; LDL-C: low-density lipoprotein-cholesterol; PLIN: perilipin; SORT1: sortilin 1; TG: triglyceride; VLDL: very low-density lipoprotein; Vps10: vacuolar protein sorting 10.

Complicated trafficking behaviors involved in paradoxical regulation of sortilin in lipid metabolism

Implications of Sortilin in Lipid Metabolism and Lipid Disorder Diseases

New Insight into Sortilin in Controlling Lipid Metabolism and the Risk of Atherogenesis

Sortilin: A novel regulator in lipid metabolism and atherogenesis

Mechanism underlying the regulation of sortilin expression and its trafficking function

Sortilin and its potential role in cardiovascular pathology

Emerging Roles of Sortilin in Affecting the Metabolism of Glucose and Lipid Profiles

Sortilin 1 Modulates Hepatic Cholesterol Lipotoxicity in Mice via Functional Interaction with Liver Carboxylesterase 1

Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin

Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein

Impaired chaperone-mediated autophagy leads to abnormal SORT1 (sortilin 1) turnover and CES1-dependent triglyceride hydrolysis

Sortilin: a New Player in Dementia and Alzheimer-type Neuropathology

Interaction of sortilin with apolipoprotein E3 enables neurons to use long-chain fatty acids as alternative metabolic fuel

Triglyceride Metabolism and Angiopoietin-Like Proteins in Lipoprotein Lipase Regulation

Ox‐LDL activates ERK signaling to downregulate sortilin expression in LSECs

Sortilin Controls Intracellular Sorting of Brain-Derived Neurotrophic Factor to the Regulated Secretory Pathway

ATG14 and STX18: gatekeepers of lipid droplet degradation and the implications for disease modulation

Lipophagy and Liver Disease: New Perspectives to Better Understanding and Therapy.

Sortilin-mediated translocation of mitochondrial ACSL1 impairs adipocyte thermogenesis and energy expenditure in male mice

Insulin Resistance Causes Posttranslational Downregulation of Hepatic Sortilin 1 in Diabetic Mice

Routes and Mechanisms of Post‐endosomal Cholesterol Trafficking: A Story That Never Ends